Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis

被引：93

作者：

Mowzoon, N ^{[1
]}

Sussman, A ^{[1
]}

Bradley, WG ^{[1
]}

机构：

[1] Univ Miami, Sch Med M712, Dept Neurol, Miami, FL 33101 USA

来源：

JOURNAL OF THE NEUROLOGICAL SCIENCES | 2001年 / 185卷 / 02期

关键词：

mycophenolate; myasthmia gravis; chronic inflammatory; demyelinating polyneuropathy; polymyositis; inclusion body myositis; therapy;

D O I：

10.1016/S0022-510X(01)00478-6

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

We report favorable results of the long term use of mycophenolate in the treatment of three patients with myasthenia gravis (MG), two patients with chronic inflammatory demyelinating polyneuropathy (CIDP), one patient with secondary polymyositis (PM). and one patient with inclusion body myositis (IBM). Side effects were mild. Mycophenolate: appears to be a useful addition to the armamentarium of immunosuppressants for treatment of chronic immunologically mediated neuromuscular diseases. (C) 2001 Elsevier Science B.V. All rights reserved.

引用

页码：119 / 122

页数：4

共 11 条

[1] Mycophenolate mofetil impairs transendothelial migration of allogeneic CD4 and CD8 T-cells [J].

Blaheta, RA ;

Leckel, K ;

Wittig, B ;

Zenker, D ;

Oppermann, E ;

Harder, S ;

Scholz, M ;

Weber, S ;

Encke, A ;

Markus, BH .

TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) :1250-1252

[2] Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation [J].

Bornhäuser, M ;

Schuler, U ;

Pörksen, G ;

Naumann, R ;

Geissler, G ;

Thiede, C ;

Schwerdtfeger, R ;

Ehninger, G ;

Thiede, HM .

TRANSPLANTATION, 1999, 67 (04) :499-504

[3] Mycophenolate mofetil: A safe and promising immunosuppressant in neuromuscular diseases [J].

Chaudhry, V ;

Cornblath, DR ;

Griffin, JW ;

O'Brien, R ;

Drachman, DB .

NEUROLOGY, 2001, 56 (01) :94-96

[4] Mycophenolate mofetil for myasthenia gravis: An open-label pilot study [J].

Ciafaloni, E ;

Massey, JM ;

Tucker-Lipscomb, B ;

Sanders, DB .

NEUROLOGY, 2001, 56 (01) :97-99

[5] Successful treatment of a patient with severe refractory myasthenia gravis using mycophenolate mofetil [J].

Hauser, RA ;

Malek, AR ;

Rosen, R .

NEUROLOGY, 1998, 51 (03) :912-913

[6] Cellcept enhances the rate of apoptosis in T cells after renal transplantation [J].

Kasprzycka, M ;

Wierzbicki, P ;

Nowaczyk, M ;

Górski, A ;

Serafinowicz, A ;

Durlik, M ;

Wyzgal, J ;

Korczak-Kowalska, G ;

Gradowska, L ;

Chmura, A .

TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) :328-328

[7]

Meriggioli MN, 2000, MUSCLE NERVE, V23, P1287, DOI 10.1002/1097-4598(200008)23:8<1287::AID-MUS22>3.0.CO

[8]

2-L

[9]

Shipkova M, 1998, CLIN CHEM, V44, P1481

[10]

Sievers TM, 1997, PHARMACOTHERAPY, V17, P1178

← 1 2 →